☆ 4.6 Letter

Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry

BRITISH JOURNAL OF DERMATOLOGY (2022)

Get Full Text
Add to Collection

Journal

BRITISH JOURNAL OF DERMATOLOGY
Volume 187, Issue 6, Pages 1022-1024

Publisher

WILEY
DOI: 10.1111/bjd.21794

Keywords

-

Categories

Dermatology

Funding

  1. AbbVie GmbH Co KG
  2. Lilly Deutschland GmbH
  3. Pfizer Inc.
  4. Sanofi Deutschland GmbH
  5. Galderma SA
  6. LEO Pharma GmbH

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.